Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...
GlobalData on MSN1d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
The details you provide on this page will not be used to send unsolicited email ... approval of the drug and WHO pre-qualification. The drug has been approved in Europe and the US as a treatment for ...
From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...
Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...
Professor Harry Hausler, the CEO of TB HIV Care and a former technical advisor to the national Department of Health on TB/HIV, believes the main reason for this “massive” uptick in blood-borne ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
At issue here is a county government’s contention — despite scientific evidence to the contrary — that needle exchange ...
MONTREAL - Theratechnologies (NASDAQ:THTX) Inc. (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company, has revealed details from a study focusing on the treatment outcomes for heavily treatment ...
The AIDS Society of India (ASI) has called on the government to swiftly integrate HIV self-testing and pre-exposure ...
It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are also HIV positive as it is from donors who are not infected with the virus ...
The national HIV prevalence was 16. 3% among adults aged 15 years and older, translating to an estimated 7. 4 million adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback